PTEN Status Predicts Prostate Cancer Outcomes as Well as Multigene Panel PTEN Status Predicts Prostate Cancer Outcomes as Well as Multigene Panel

PTEN loss by tumor immunohistochemistry (IHC) predicts prostate-cancer outcomes after radical prostatectomy as well as a commercial multigene panel does.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news